Dr. Reddy's gets tentative US OK for pantoprazole

MUMBAI, Dec 24 (Reuters) - India's Dr. Reddy's Laboratories Ltd (REDY.BO)(RDY.N) has received tentative approval from the U.S. Food and Drug Administration for heartburn drug pantoprazole sodium in the extended release tablet format, the regulator's Web site showed.

(Reporting by Rina Chandran; Editing by John Mair)

((rina.chandran@reuters.com; +91 22 6636 9251; Reuters Messaging: rina.chandran.reuters.com@reuters.net)) Keywords: REDDYS FDA/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nBOM261603